New paper
Association Between Dietary Total Fat and Cholesterol Intake and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Cohort and Case-Control Studies.
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New paper
Pancreatoblastoma: A Descriptive and Comparative Analysis with Pancreatic Ductal Adenocarcinoma Using SEER Data.
Why it was picked newest record on or before this date
New paper
Specific targeting of cancer cell mitochondria with a malaria drug improves pancreatic cancer outcome.
Why it was picked newest record on or before this date
New paper
Six-month progression-free survival-related tumor growth rate after upfront chemotherapy as an outcome measure and potential prognostic or stratification variable for patients with unresectable pancreatic adenocarcinoma: an exploratory study cohorts analysis.
Why it was picked newest record on or before this date
New paper
Progress in the application of 177Lu- and 225Ac-targeted radionuclide therapy in pancreatic ductal adenocarcinoma.
Why it was picked newest record on or before this date
Also today
New paper
Phytochemicals as Multitarget Therapeutics in Pancreatic Cancer: Mechanisms, Clinical Evidence, and Translational Challenges.
New trial
A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer
New trial
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
New paper
Adaptive Surgical Decision-Making for Synchronous Metastatic Pancreatic Cancer and Early Breast Cancer with a BRCA1 Pathogenic Variant: A Case Report.
Change tracking began 4 November 2026, after this day, so only its new records are listed.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.